8-K: Agilent Exceeds Q3 Revenue, Raises Full-Year Outlook

Agilent Technologies reported strong third-quarter fiscal year 2025 financial results, exceeding revenue guidance and raising its full-year outlook.

Summary

• Third-quarter fiscal year 2025 revenue reached $1.74 billion, surpassing guidance and growing 10.1% reported and 6.1% on a core basis compared with the third quarter of 2024.
• GAAP net income for the quarter was $336 million, or $1.18 per share, a 22% increase from the third quarter of 2024.
• Non-GAAP net income was $390 million, or $1.37 per share, up 4% from the third quarter of 2024.
• This marks the fifth consecutive quarter of sequential core-revenue acceleration.
• All three business groups (Life Sciences and Diagnostics Markets, Agilent CrossLab, Applied Markets), all regions, and the two largest markets experienced growth.
• The full-year fiscal 2025 revenue outlook has been revised to a range of $6.91 billion to $6.93 billion, representing 6.2% to 6.5% reported growth and 4.3% to 4.6% core growth.
• Full-year non-GAAP EPS is now expected in the range of $5.56 to $5.59.
• Fourth-quarter revenue outlook is expected to be in the range of $1.822 billion to $1.842 billion, with non-GAAP EPS projected between $1.57 and $1.60 per share.

Sentiment

Score: 8

Explanation: The company delivered strong financial results, exceeding revenue guidance and demonstrating consistent core revenue acceleration. The raised full-year outlook and growth across all segments and regions indicate robust operational performance and effective strategic execution, despite some margin compression and a dynamic tariff environment.

Positives

• Exceeded third-quarter revenue guidance with reported revenue of $1.74 billion.
• Achieved strong reported revenue growth of 10.1% and core growth of 6.1% year-over-year.
• GAAP earnings per share (EPS) increased significantly by 22% to $1.18.
• Reported the fifth consecutive quarter of sequential core-revenue acceleration.
• All three business groups (Life Sciences and Diagnostics Markets, Agilent CrossLab, Applied Markets) demonstrated growth.
• All geographic regions and the two largest markets also experienced growth.
• Raised the full-year fiscal 2025 revenue outlook to a range of $6.91 billion to $6.93 billion.
• Raised the full-year fiscal 2025 non-GAAP EPS outlook to a range of $5.56 to $5.59.

Negatives

• Non-GAAP EPS growth was modest at 4% ($1.37 vs $1.32) compared to the 22% GAAP EPS growth, indicating significant non-GAAP adjustments.
• Operating margins for all three segments decreased year-over-year: Life Sciences and Diagnostics Markets Group from 19.6% to 17.6%, Agilent CrossLab Group from 35.9% to 33.3%, and Applied Markets Group from 23.2% to 21.8%.
• The company noted the impact of a 'dynamic tariff environment' on results.

Risks

• Unforeseen changes in the strength of customer businesses.
• Unforeseen changes in demand for current and new products, technologies, and services.
• Unforeseen changes in currency markets.
• Customer purchasing decisions and timing.
• Risk of not realizing expected savings from integration and restructuring activities.
• Ability to execute successfully through business cycles.
• Ability to meet and achieve benefits of operational transformation, market-focused strategy, and cost-reduction goals.
• Ongoing competitive, pricing, and gross-margin pressures.
• Risk that cost-cutting initiatives impair ability to develop products, remain competitive, and operate effectively.
• Impact of geopolitical uncertainties and global economic conditions on operations and markets.
• Ability to improve asset performance to adapt to changes in demand.
• Impact relating to or arising from changes to tariffs, import/export, or trade policies.
• Ability of the supply chain to adapt to changes in demand.
• Ability to successfully introduce new products at the right time, price, and mix.
• Ability to successfully integrate recent acquisitions.
• Ability to successfully comply with certain complex regulations.

Future Outlook

Agilent revised its full-year fiscal 2025 revenue outlook to a range of $6.91 billion to $6.93 billion, representing 6.2% to 6.5% reported growth and 4.3% to 4.6% core growth. Full-year non-GAAP EPS is expected between $5.56 and $5.59. For the fourth fiscal quarter, revenue is projected to be between $1.822 billion and $1.842 billion, with non-GAAP EPS in the range of $1.57 to $1.60 per share. This outlook is based on forecasted currency exchange rates.

Management Comments

• "Our third-quarter performance, which marks our fifth consecutive quarter of sequential core-revenue acceleration, is a testament to the success of our Ignite Transformation and our laser-like focus on profitable growth and operational excellence."
• "All three of our business groups grew, along with all regions and our two largest markets."
• "Our Ignite enterprise operating model enables us to nimbly and quickly navigate a highly dynamic macro environment while remaining focused on our strong execution, innovation pipeline, and deep customer relationships."

Industry Context

Agilent Technologies operates as a global leader in analytical and clinical laboratory technologies. The reported results demonstrate the company's ability to achieve strong revenue growth and sequential core-revenue acceleration despite a dynamic macro environment and tariff challenges, suggesting effective strategic execution and robust demand within its specialized markets.

Comparison to Industry Standards

• The filing does not provide specific comparable companies, projects, or global benchmarks to assess the results against industry standards. Management notes that non-GAAP information facilitates internal comparisons to historical operating results and comparisons to competitors' operating results, but these specific comparisons are not detailed in the release.

Stakeholder Impact

• Shareholders: Positive impact due to strong financial performance, exceeding guidance, significant GAAP EPS growth, and a raised full-year outlook, which could lead to increased share value.
• Employees: The 'Ignite Transformation' and focus on operational excellence suggest ongoing strategic initiatives that may impact employees, though the filing highlights positive execution.
• Customers: The company emphasizes strong execution, innovation pipeline, and deep customer relationships, indicating a continued focus on delivering value and maintaining customer satisfaction.

Next Steps

• Agilent's management will present additional details regarding the third-quarter 2025 financial results on a conference call with investors on August 27, 2025, at 1:30 p.m. PT.
• The company will continue to execute its Ignite Transformation and maintain focus on profitable growth, operational excellence, innovation pipeline, and customer relationships.

Key Dates

Recommendation

Agilent Technologies delivered impressive Q3 FY2025 results, surpassing revenue guidance and demonstrating robust core revenue acceleration for the fifth consecutive quarter. The significant 22% GAAP EPS growth and the upward revision of the full-year revenue and non-GAAP EPS outlook signal strong underlying business momentum and effective management in a dynamic market. Growth across all business segments and regions further reinforces the company's broad-based strength. While operating margins saw a slight dip, the overall performance and optimistic guidance suggest a compelling investment opportunity.

Keywords

Agilent Technologies, financial results, Q3 2025, earnings, revenue, EPS, life sciences, diagnostics, analytical instruments, laboratory technology, core growth, outlook, corporate earnings, NYSE: A